ZA908801B - Process for purifying antigenic factors from b.pertussis - Google Patents
Process for purifying antigenic factors from b.pertussisInfo
- Publication number
- ZA908801B ZA908801B ZA908801A ZA908801A ZA908801B ZA 908801 B ZA908801 B ZA 908801B ZA 908801 A ZA908801 A ZA 908801A ZA 908801 A ZA908801 A ZA 908801A ZA 908801 B ZA908801 B ZA 908801B
- Authority
- ZA
- South Africa
- Prior art keywords
- pertussis
- antigenic factors
- purifying
- purifying antigenic
- fha
- Prior art date
Links
- 241000588832 Bordetella pertussis Species 0.000 title abstract 2
- 230000000890 antigenic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000012228 culture supernatant Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Semiconductor Lasers (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43199989A | 1989-11-06 | 1989-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA908801B true ZA908801B (en) | 1991-11-27 |
Family
ID=23714322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA908801A ZA908801B (en) | 1989-11-06 | 1990-11-02 | Process for purifying antigenic factors from b.pertussis |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0427462B1 (pt) |
JP (1) | JP3148895B2 (pt) |
KR (1) | KR0161281B1 (pt) |
AT (1) | ATE134194T1 (pt) |
AU (1) | AU635083B2 (pt) |
CA (1) | CA2029201C (pt) |
CY (1) | CY1934A (pt) |
DE (1) | DE69025375T2 (pt) |
DK (1) | DK0427462T3 (pt) |
ES (1) | ES2084668T3 (pt) |
GR (1) | GR3019725T3 (pt) |
HK (1) | HK1004555A1 (pt) |
IE (1) | IE71687B1 (pt) |
NZ (1) | NZ235960A (pt) |
PT (1) | PT95789B (pt) |
ZA (1) | ZA908801B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA40596C2 (uk) | 1992-05-23 | 2001-08-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини та спосіб її одержання |
ATE183194T1 (de) * | 1994-04-28 | 1999-08-15 | Takeda Chemical Industries Ltd | Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis |
DE19512346C1 (de) * | 1995-04-01 | 1996-06-13 | Behringwerke Ag | Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin |
GB0313916D0 (en) | 2003-06-16 | 2003-07-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
PL2809343T3 (pl) | 2012-02-01 | 2018-03-30 | Glaxosmithkline Biologicals S.A. | Sposób fermentacji |
US8916173B2 (en) | 2013-03-08 | 2014-12-23 | Crucell Holland B.V. | Acellular pertussis vaccine |
WO2019180507A1 (en) | 2018-03-20 | 2019-09-26 | Sanofi Pasteur Limited | Methods of cultivating bordetella species |
KR102362777B1 (ko) * | 2018-03-27 | 2022-02-15 | 주식회사 녹십자 | 친화성 크로마토그래피 공정을 포함하는 백일해균 유래 단백질 수득 방법 |
US11273859B2 (en) * | 2018-03-27 | 2022-03-15 | Nsk Ltd. | Steering device |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4500639A (en) | 1981-10-15 | 1985-02-19 | Teijin Limited | Culturing Bordetella in media containing etherified cyclodextrin |
JPS59175439A (ja) | 1983-03-23 | 1984-10-04 | Teijin Ltd | 繊維状赤血球凝集素の製法 |
CA1213234A (en) | 1983-03-30 | 1986-10-28 | Akihiro Ginnaga | Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine |
JPS6098988A (ja) | 1983-11-01 | 1985-06-01 | Chemo Sero Therapeut Res Inst | Lpf−haの精製法 |
AU571078B2 (en) | 1984-04-14 | 1988-03-31 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Purification of filamentous hemagglutinin |
GB8601279D0 (en) | 1986-01-20 | 1986-02-26 | Public Health Lab Service | Purification of pertussis antigens |
FR2596413B1 (fr) | 1986-03-27 | 1988-06-10 | Merieux Inst | Nouveaux milieux de culture de bacteries appartenant au genre bordetella, contenant des derives etherifies de polymeres de d-glucose, et leur application |
-
1990
- 1990-11-01 DK DK90311979.0T patent/DK0427462T3/da active
- 1990-11-01 ES ES90311979T patent/ES2084668T3/es not_active Expired - Lifetime
- 1990-11-01 AT AT90311979T patent/ATE134194T1/de not_active IP Right Cessation
- 1990-11-01 CY CY193490A patent/CY1934A/xx unknown
- 1990-11-01 EP EP90311979A patent/EP0427462B1/en not_active Expired - Lifetime
- 1990-11-01 DE DE69025375T patent/DE69025375T2/de not_active Expired - Lifetime
- 1990-11-02 CA CA002029201A patent/CA2029201C/en not_active Expired - Lifetime
- 1990-11-02 ZA ZA908801A patent/ZA908801B/xx unknown
- 1990-11-02 IE IE396990A patent/IE71687B1/en not_active IP Right Cessation
- 1990-11-05 KR KR1019900017845A patent/KR0161281B1/ko not_active IP Right Cessation
- 1990-11-05 JP JP29737390A patent/JP3148895B2/ja not_active Expired - Lifetime
- 1990-11-05 NZ NZ235960A patent/NZ235960A/xx unknown
- 1990-11-05 PT PT95789A patent/PT95789B/pt not_active IP Right Cessation
- 1990-11-05 AU AU65846/90A patent/AU635083B2/en not_active Expired
-
1996
- 1996-04-23 GR GR960401110T patent/GR3019725T3/el unknown
-
1998
- 1998-04-28 HK HK98103621A patent/HK1004555A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0427462A1 (en) | 1991-05-15 |
PT95789A (pt) | 1991-09-13 |
KR0161281B1 (ko) | 1998-12-01 |
NZ235960A (en) | 1993-11-25 |
DK0427462T3 (da) | 1996-03-11 |
JPH03169893A (ja) | 1991-07-23 |
AU6584690A (en) | 1991-05-09 |
GR3019725T3 (en) | 1996-07-31 |
IE903969A1 (en) | 1991-05-08 |
AU635083B2 (en) | 1993-03-11 |
CA2029201A1 (en) | 1991-05-07 |
PT95789B (pt) | 1997-12-31 |
EP0427462B1 (en) | 1996-02-14 |
HK1004555A1 (en) | 1998-11-27 |
CY1934A (en) | 1990-11-01 |
DE69025375T2 (de) | 1996-08-01 |
ES2084668T3 (es) | 1996-05-16 |
ATE134194T1 (de) | 1996-02-15 |
IE71687B1 (en) | 1997-02-26 |
KR910009283A (ko) | 1991-06-28 |
DE69025375D1 (de) | 1996-03-28 |
JP3148895B2 (ja) | 2001-03-26 |
CA2029201C (en) | 2002-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG17972A (en) | Process for the extraction and purification of proteins from culture media producing them | |
IL96779A0 (en) | Process for the production and extraction of antioxidants from a micro-organism culture and photobioreactor for performing this process | |
EP0430645A3 (en) | Vaccines | |
ZA908801B (en) | Process for purifying antigenic factors from b.pertussis | |
EP0231083A3 (en) | Purification of pertussis antigens | |
FI101380B1 (fi) | Menetelmä 69 000 daltonin antigeeniproteiinin puhdistamiseksi Bordetella pertussis -bakteerista | |
IL113595A0 (en) | Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain | |
AU601415B2 (en) | A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine | |
EP0090660A3 (en) | Neisseria gonorrhoeae vaccine | |
NO885777D0 (no) | Fremgangsmaate for rensing av granulocytt/makrofagkoloniistimulerende faktor. | |
DE3364803D1 (en) | Method of preparing an immunogen of pasteurella multocida | |
AU603794B2 (en) | Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus | |
ZA868611B (en) | Fermentation methods for hepatitis vaccine production | |
DE58906674D1 (de) | Verfahren zur Auswahl produktiver, Aminosäuren ausscheidender Stämme von Mikroorganismen. | |
GB9027901D0 (en) | Acellular vaccine | |
NZ215359A (en) | Culture media for microorganisms | |
GR862720B (en) | Fermentation methods for hepatitis vaccine production | |
BR9601748A (pt) | Desenvolvimento de vacina acelular anti-coqueluche por etapa única de purificaç o de sobrenadante ou filtrado de cultura de bordetella pertussis |